Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Iv Administration Equipment Supplied In Europe
6 equipment items found
Manufactured by:eTheRNA based inNiel, BELGIUM
Therapeutic area: cancer vaccines; Systemic, intravenous (IV) ...
Manufactured by:Matek Medikal based inYenimahalle, TURKEY
The intraosseous cavity can be considered as a large vessel suitable for use at all times, independent of the patient’s hemodynamic (blood pressure) status. Today, intraosseous route is regarded equal to intravenous (IV) route for administration of drugs and other fluids to children and ...
Manufactured by:Leventon S.A.U. based inBarcelona, SPAIN
DOSI-FLOW 10, 20, 30 is an ergonomic design of high precision flow regulator that constitutes a practical and reliable solution when therapy requires an infusion at a specific flow rate and for a specific ...
Manufactured by:Leventon S.A.U. based inBarcelona, SPAIN
DOSI-FLOW 1, 2, 3 is a high-precision flow regulator that constitutes a practical and reliable solution when therapy requires an infusion at a specific flow rate and for a specific ...
Manufactured by:MerLion Pharmaceuticals GmbH based inBerlin, GERMANY
Finafloxacin is a novel candidate for the treatment of multiple, life-threatening infection indications, like complicated urinary tract infections (cUTIs). Coming from a well-known and well understood “workhorse” class of antibiotic, its unique properties in activity, safety and flexible dosing regimen options, clearly distinguish finafloxacin from other, existing therapies, offering ...
Manufactured by:Ascelia Pharma AB based inMalmö, SWEDEN
Oncoral is a novel daily irinotecan chemotherapy in development. Irinotecan chemotherapy has an established potent anti-tumor effect – even in difficult to treat cancers. Oncoral is a daily irinotecan tablet with the potential to offer better patient outcomes with improved safety following the daily dosing at home compared to intravenous high-dose infusions at the hospital. Following ...